Pfizer’s subsidiary Biohaven has agreed to a settlement nearing $60 million to resolve allegations of false claims related to ...
AbbVie is a Dividend King that's quickly moving past reliance on Humira. Enbridge shouldn't be affected by potential Canadian ...
The kickbacks were meant to encourage doctors to prescribe the migraine drug Nurtec ODT, which is a violation of the False Claims Act, the U.S. Department of Justice said. In October 2022, Pfizer ...
Florida's Medicaid Fraud Control Unit secured the win through a multistate action. "Actions, like those alleged here, must be ...
Pfizer reported strong 2024 profits Wednesday on the same day the Connecticut Attorney General’s office released a statement ...
Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...
Pfizer subsidiary Biohaven allegedly gave physicians speaker honoraria and meals at high-end restaurants to induce them to ...
The Michigan Attorney General’s Office says the state has joined 37 other states and the territory of Puerto Rico in the ...
Pfizer posted Q4 revenue of $17.76 billion, up 22% YoY, with strong sales from Paxlovid, Vyndaqel, and Eliquis. The company reaffirmed its 2025 revenue outlook.
Michigan has joined the U.S. Department of Justice, 37 other states and Puerto Rico in settling kickback allegations against a Pfizer, Inc. subsidiary. Pfizer has agreed to ...
Pfizer expects to sufficiently de-lever its balance sheet ... loss of patent-based exclusivity and generic competition in certain international markets; Nurtec ODT/Vydura globally, up 39% ...
Pfizer Inc. (NYSE:PFE – Get Free Report) shares traded up 2.9% on Wednesday following a stronger than expected earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results